CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has initiated a Phase 1/2 clinical trial with ALN-AAT, a ...

AAT-076 was tested in the preclinical setting for its analgesic potential in COX-1 and COX-2 assays, as well as in in vivo rat models of air pouch inflammation, adjuvant-induced arthritis and ...

@2024 - All Right Reserved.

BEAM-302 demonstrated safety and efficacy in increasing AAT levels and reducing mutant protein in alpha-1 antitrypsin deficiency patients. Beam Therapeutics announced promising initial results from ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in AROAAT2002, an open-label Phase 2 clinical study of ARO-AAT, the ...

MANASSAS, VIRGINIA, UNITED STATES, January 26, 2024 / EINPresswire.com / -- Sanofi’s recent acquisition of a recombinant alpha-1 antitrypsin (AAT) drug candidate for $2.2 billion highlights the ...

JEE Advanced AAT result 2025: The Indian Institute of Technology Madras has announced the results of the Architecture Aptitude Test (AAT) 2025, conducted as part of the JEE (Advanced) examination ...

An accounting lecturer at The Sheffield College is a finalist in a national industry award. Dean Quartermaine, AAT course ...

Member of the then-Administrative Appeals Tribunal (AAT), Vanessa Plain, was recently criticised by the Federal Circuit and Family Court of Australia (FCFCOA) for her “important or noteworthy” cut-and ...